| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 俞鹏程 | 国新证券股份 | None | 74.65% | 42.54% | 9.78% | 100.00% | 1 | 0.00% | 2013-12-31 |
| 2 | 曾知 | 海通证券 | None | 74.47% | 74.47% | 34.43% | 20.93% | 1 | -44.28% | 2013-12-31 |
| 3 | 李亚军 | 国信证券 | None | 74.43% | 0.00% | 0.00% | -58.62% | 0 | -51.90% | 2019-12-31 |
| 4 | 王健超 | 广州广证恒生市场研究 | None | 73.73% | 75.36% | 31.49% | 100.00% | 6 | 0.00% | 2013-12-31 |
| 5 | 欧阳仕华 | 国信证券 | None | 73.66% | 41.86% | 12.80% | -0.97% | 45 | -59.03% | 2019-12-31 |
| 6 | 谭倩 | 华鑫证券 | None | 73.44% | 21.37% | -3.51% | -11.44% | 12 | -65.41% | 2021-12-31 |
| 7 | 惠毓伦 | 广发证券 | None | 73.14% | 45.93% | 7.01% | 44.00% | 16 | -29.43% | 2013-12-31 |
| 8 | 郑奇威 | 东方证券 | None | 73.12% | 52.50% | 13.70% | 100.00% | 1 | 0.00% | 2014-12-31 |
| 9 | 罗佳荣 | 广发证券 | 医药生物 | 72.45% | 26.46% | 6.90% | -2.15% | 12 | -76.45% | 2019-12-31 |
| 10 | 马瑞山 | 光大证券 | None | 72.40% | 33.40% | 16.88% | 71.43% | 0 | -8.72% | 2021-12-31 |
| 11 | 刘芷君 | 广发证券 | None | 72.32% | 62.23% | 14.00% | -50.00% | 1 | -61.84% | 2014-12-31 |
| 12 | 李会坤 | 国海证券 | None | 72.26% | 62.67% | -5.91% | 23.81% | 7 | -58.44% | 2014-12-31 |
| 13 | 邓永康 | 民生证券 | 电力设备 | 72.04% | 37.96% | 11.48% | -16.42% | 50 | -78.11% | 2021-12-31 |
| 14 | 吴非 | 中信证券 | None | 71.99% | 63.88% | 35.12% | 54.55% | 12 | -25.16% | 2014-12-31 |
| 15 | 梁荣 | 国泰海通 | None | 71.86% | 71.17% | 52.97% | 100.00% | 0 | 0.00% | 2014-12-31 |
| 16 | 钱建江 | 太平洋 | None | 71.86% | 25.48% | 16.70% | -2.56% | 13 | -67.90% | 2019-12-31 |
| 17 | 蒲东君 | 长江证券 | None | 71.79% | -1.61% | 14.18% | 13.79% | 1 | -32.36% | 2021-12-31 |
| 18 | 张文臣 | 太平洋 | 电力设备 | 71.73% | 40.51% | 10.30% | -2.82% | 6 | -76.67% | 2021-12-31 |
| 19 | 于潇 | 民生证券 | None | 71.28% | 28.45% | 7.85% | 61.90% | 29 | -43.65% | 2021-12-31 |
| 20 | 冯大军 | 中国银河 | None | 70.69% | 10.42% | 3.91% | 100.00% | 4 | 0.00% | 2013-12-31 |